Clinical Trials Logo

Fasciitis clinical trials

View clinical trials related to Fasciitis.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06466616 Active, not recruiting - Plantar Fascitis Clinical Trials

Shock Waves Combined With Leg Stretches in Patients With Plantar Fasciitis

Start date: May 6, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of a combination treatment consisting of ESWT and stretching of different muscles in the lower body compared to ESWT treatment alone in patients with plantar fasciitis.

NCT ID: NCT05915091 Active, not recruiting - Plantar Fascitis Clinical Trials

Comparative Effects of Dry Needling and Cross Friction Massage on Patients With Plantar Fascitis, RCT

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Effectiveness Comparative Effects of Dry Needling and Cross Friction Massage on Patients With Plantar Fascitis

NCT ID: NCT05763381 Active, not recruiting - Plantar Fascitis Clinical Trials

Low-Level Laser Therapy for Plantar Fasciitis

Start date: August 11, 2022
Phase: N/A
Study type: Interventional

Plantar fasciitis (PF), a degenerative injury of the connective tissue in the foot, results in pain-related disability in Service Members and contributes to decreased physical activity and excessive healthcare costs. Even if effective, current treatment protocols may require 6-12 months of therapy to return individuals to pain-free activity. Photobiomodulation therapy (PBMT) uses non-ionizing light to elicit biological changes in tissues resulting in beneficial therapeutic outcomes. Evidence supports use of PBM for other degenerative connective tissue conditions, such as achilles tendinopathy and epicondylitis. A previous pilot study was completed in an active-duty military and civilian population, which demonstrated a positive effect of two PBM dose parameters on function and pain levels in participants with chronic PF when combined with stretching and ice. These positive findings from the aforementioned study are promising in the treatment of this common and debilitating issue, but require the addition of a sham comparison to rigorously eliminate any potential placebo effect of the treatment protocol, and further refine the treatment protocol in order to make evidence-based clinical recommendations. As such, proposing a follow-up study and the addition of an objective outcome measure will strengthen the impact of the study. SPECIFIC AIM 1: To assess the clinical effectiveness of photobiomodulation compared to sham photobiomodulation to improve function and decrease pain. SPECIFIC AIM 2: To evaluate the effectiveness of photobiomodulation compared to sham photobiomodulation to resolve plantar fascial thickening. DESIGN: A prospective randomized sham-controlled trial to meet the aims of the study. METHOD: A sample of up to 100 active-duty military members will be randomly assigned to the Sham-PBMT or PBMT group. At baseline, during the treatment protocol, and at long-term (3 and 6 months) follow-up, measures of foot function, pain, and plantar fascial thickness will be collected for analysis. The proposed methods will allow the study team to establish if PBMT is clinically effective to accelerate recovery compared to Sham-PBMT and result in resolution of fascial thickening, decrease in pain, and improved function. LONG-TERM GOAL: The long-term goals of the research include developing PBMT protocols for broad application to other painful and duty-limiting conditions.

NCT ID: NCT05367271 Active, not recruiting - Plantar Fasciitis Clinical Trials

The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis

Start date: August 23, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of care corticosteroid injections to the plantar fascia for the treatment of refractory plantar fasciitis in patients that have failed six weeks of non-operative treatment.

NCT ID: NCT05162144 Active, not recruiting - Clinical trials for Chronic Plantar Fasciitis

Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis

Start date: December 15, 2021
Phase: N/A
Study type: Interventional

This prospective kohort study will follow 150 patients treated with proximal medial gastrocnemius recession for plantar fasciitts. Follow up time is two years and the main outcome is the Manchester Oxford Foot Questionnaire. A regression analasys will be performed to identify possible patient baseline factors that may affect the effect of surgery,

NCT ID: NCT04444102 Active, not recruiting - Inflammation Clinical Trials

The Acute Impact of Yoga-based Stretching on Inflammation and Its Resolution

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

The goal of this study is to explore the impact of two types of yoga-based body stretching (mild and intense) on dynamic changes of Systemic Inflammatory Cytokines (SICs) and Specialized Pro-resolving Mediators (SPMs) in yoga-naïve subjects.

NCT ID: NCT04332471 Active, not recruiting - Plantar Fascitis Clinical Trials

Shockwave Therapy for Plantar Fasciitis RCT

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis. Several studies have compared the effects of different types of extracorporeal shockwave therapy (radial and focused) with other forms of conservative treatment in patients with chronic plantar fasciitis. No study has yet compared the effect of radial vs. focused shockwave therapy on pain in this population.

NCT ID: NCT02982226 Active, not recruiting - Fasciitis, Plantar Clinical Trials

ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis

Start date: September 2016
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to evaluate both the safety and efficacy of the ReNu™ injection on pain and inflammation in subjects diagnosed with plantar fasciitis as compared to a Corticosteroid Injection which is considered standard of care.

NCT ID: NCT02116478 Active, not recruiting - Plantar Fasciitis Clinical Trials

Gastrocnemius Recession vs. Conservative Treatment for Chronic Plantar Fasciitis

Start date: August 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the clinical results for patients suffering from plantar fasciitis treated with gastrocnemius recession vs. conservative treatment.

NCT ID: NCT01911572 Active, not recruiting - Clinical trials for Invasive Group B Streptococcal Disease

Genetic Susceptibility to Severe Streptococcal Infections

Start date: December 2013
Phase:
Study type: Observational

Invasive bacterial infection is a dangerous but relatively uncommon disease where bacteria spread deep into the body causing diseases like blood poisoning ('bacteraemia'), pneumonia, meningitis and others. The various bacteria of the streptococcus family are an important cause, often leading patients to require intensive care despite which, for some strains, one in five patients die. One notable form is called necrotising fasciitis, a condition where bacteria rapidly spreads through and destroys the layers of tissue just under the skin. As individuals vary greatly in their risk of developing such serious infections, investigating how the genome, the inherited blueprint of our bodies, of these patients differs from that of healthy volunteers can help to explain why the disease develops in some and not others. For some streptococcal bacteria such as Streptococcus pneumoniae this approach is already proving successful; for others such as the "Group A" strain (Streptococcus pyogenes) it has yet to be explored but carries excellent potential. The investigators have secured the support of the Lee Spark Necrotising Fasciitis Foundation to recruit from their membership survivors of streptococcal infections and some of their family members. The investigators will also ask infection specialists from NHS hospitals to invite patients they have looked after. The investigators also have a small existing collection. Taking part would involve registering information on a website, discussing the study on the telephone and then providing us with a sample of saliva from which the investigators can isolate DNA. The investigators would prepare the sample for analysis of the genome and compare the patients with both their family and an existing reference collection from healthy volunteers using technology that reads the DNA code. Our study will be a first key step in renewing efforts to understand the determinants of invasive streptococcal infection, which is important for developing better treatments and vaccines.